Third Harmonic Bio Inc (THRD) Noticias

Third Harmonic Bio to Participate in Upcoming Investor Conferences in November

SAN FRANCISCO, Nov. 07, 2024 (GLOBE NEWSWIRE) -- Third Harmonic Bio, Inc. (Nasdaq: THRD), a clinical-stage biopharmaceutical company focused on...

Form 8-K - Current report

Third Harmonic Bio Announces Third Quarter 2024 Financial Results

THB335 Phase 1 SAD/MAD clinical trial on track to deliver clinical results in 1Q’25 Strong financial position with cash and cash equivalents...

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form SC 13G - Statement of Beneficial Ownership by Certain Investors

Form 4 - Statement of changes in beneficial ownership of securities

Form 144 - Report of proposed sale of securities

Third Harmonic Bio to Participate in Upcoming Investor Conferences in September

SAN FRANCISCO, Sept. 10, 2024 (GLOBE NEWSWIRE) -- Third Harmonic Bio, Inc. (Nasdaq: THRD), a clinical-stage biopharmaceutical company focused on...

Third Harmonic Bio to Participate in Upcoming Investor Conferences

SAN FRANCISCO, Aug. 26, 2024 (GLOBE NEWSWIRE) -- Third Harmonic Bio, Inc. (Nasdaq: THRD), a clinical-stage biopharmaceutical company focused on...

Form 8-K - Current report

Third Harmonic Bio Announces Second Quarter 2024 Financial Results and Provides Business Update

THB335 Phase 1 SAD/MAD clinical trial progressing; study now on track to report clinical results in 1Q’25 Strong financial position with cash and...

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 8-K - Current report